Authors : Aditi Jhunjhunwala, Aditi Jhunjhunwala, Ram Kumar, Ram Kumar
DOI : 10.18231/j.ijooo.2021.069
Volume : 7
Issue : 3
Year : 2021
Page No : 328-332
Aim: Rhino orbital cerebral mucormycosis is an opportunistic fungal infection with high morbidity and mortality which has seen the rise during the second wave of covid 19 in our country. Aim of our study was to study the clinical course, diagnosis and management of patient of rhino orbital mucormycosis in post covid phase presenting at our tertiary care centre.
Materila and Methods: 4 cases of rhino-orbital mucormycosis who presented to us in post covid phase was followed and details recorded and analyzed to study its clinical course, diagnosis and management.
Observation: 4 patients presented to us in post covid phase with signs of orbital cellulitis like periorbital swelling with pain, drooping of eyelids, proptosis, restriction of extraocular movements, decrease and loss of vision and sluggish reacting pupil. MRI/CT of the patients showed intraconal and extraconal involvement suggestive of orbital cellulitis. Diagnostic Nasal Endoscopy (DNE) was done and tissue sent for KOH mounting, culture and histopathology. After KOH mount showed fungal hyphae, patients were started on IV liposomal amphotericin B and retrobulbar amphotericin B. Patients were then taken up for endoscopic debridement and significant improvement in proptosis, ptosis, peribulbar swelling and pain was seen in immediate post op period.
Conclusion: significant improvement was seen in patients with IV amphotericin B, retrobulbar amphotericin B and endoscopic debridement.
Key Message: Patients with rhino orbital mucormycosis can be managed with amphotericin and endoscopic debridement when exenteration is not possible.
Keywords: Clinical course, Covid 19, Fungal infection, Mucormycosis